Vaxart, Inc.’s Post

Selecting the right automation technology is crucial for streamlining workflows and maximizing efficiency. The team at Totus Medicines valued the versatility of our firefly #liquidhandling platform, which meant it could be used to automate not only #DELscreening workflows, but also technology development projects and #NGS library preparation. Learn more about the team's transition to automated liquid handling, and how it has supported their efforts in small molecule #drugdiscovery: https://bit.ly/44DBN8M

We're excited to share that our Interim CEO, Mikaela Bruhammar ♦️, will present and take part in a panel discussion on March 12 at Debiopharm Digital Day in Lausanne, Switzerland! Mikaela, in her presentation, will speak on the topic of "#RealWorldData for drug development", covering: 🔷 The impact of #digitaltransformation on data collection and analysis in clinical trials, 🔷 The potential of RWD-driven #drugdevelopment to accelerate more effective and affordable treatments, 🔷 The untapped potential of #RWD for the earlier stages of #clinicaldevelopment. #RWD #RealWorldEvidence #RWE #clinicaltrials

Exciting New Event!! 💥 On 3rd & 4th December The PBC Group - Organisers of the COG Series will host our inaugural CRO Summit in Raleigh, North Carolina. David Jones is putting together a fantastic program focussing on delivering unique takeaways for the US & Europe's vast #CRO community across the below key themes: 🤝 Collaboration: Fostering effective collaboration between sponsors, CROs, and vendors to optimize trial delivery and outcomes. 💾 Technology Integration: Leveraging cutting-edge technologies, such as digitalization, data-driven insights, and AI, to revolutionize clinical trials. 🌠 Vendor Alliances: Exploring strategies for CROs to forge strategic alliances with Functional Service Providers (FSPs) and technology vendors to gain a competitive edge in winning bids. 💰 Budgeting and Forecasting: Mastering budget management, innovative contracting, and financial forecasting for clinical trial profitability and transparency. 🏥 Site Relationships: Enabling site success through collaboration, technology, and upskilling to optimize performance in complex trials, including cell and gene therapies. 🧠 Artificial Intelligence: Harnessing AI and Large Language Models (LLMs) to streamline processes, accelerate studies, and bridge the technology gap with non-tech savvy partners. 👩👦👦 Patient Engagement: Embracing diversity, inclusion, and innovative strategies to engage and recruit patients, particularly in rare and orphan disease trials. The first of it's kind, the CRO Summit brings together operational CRO industry leaders to discuss the latest trends, challenges, and opportunities in the global #clinicaldevelopment landscape. Confirmed CRO Summit Partners: Judi by AG Mednet, Inc., Endpoint Clinical, Florence Healthcare, HeartcoR Solutions, LLC, MedNet Global Healthcare Solutions LLC, Prevail InfoWorks, SDC (Statistics & Data Corporation), TrialStat Solutions Inc., Medidata Solutions, Monitorforhire.com, BioBridges, TRYAL, Inc., Clario. Get in contact with me or David Jones directly if you’d like to get involved! https://lnkd.in/eJasJRyt

With deep #industryexpertise , huge #atmp #technicalexcellence and our #digitalfirst approach, the pinnacle is having our own #cellandgenetherapies #qp . Have a listen to what Neil has to say about adthera bio and digitally enabled #qbd mindsets

🚨 Reminder that if you're going to #DPHARM tomorrow, you can see us at Booth 65! Book a meeting slot in advance at https://hubs.li/Q02PXWV_0 And remember to set your phasers to STUNNED for a major announcement... 🤯 #Teckro #ClinicalResearch #ClinicalTrials #ClinicalTrialTech #MedTech #SitePerformance #SiteEngagement #StudyRecruitment #DPHARM2024 DPHARM: Disruptive Innovations to Modernize Clinical Research

https://lnkd.in/e_MFfBxH How to foster market adaption of digital therapeutics by means of trust? New alliance announced by DirectTrust and Digital Therapeutics Alliance to set up criteria and involve all relevant stakeholder groups aiming to give guidance and improve orientation in the rapidly evolving market of digtal health solutions. Hurdles that will coming later: How to get this trusted solutions visible and well-known by patients, customers and HCPs - label, seal, app directory? Maybe worth to look at experience and achievements of initiatives here in Europe Label2Enable, ORCHA, HealthOn - and #DiGAFastTrack application items required by Federal Institute for drugs and medical devices to get reimbursement for #DTx https://lnkd.in/eWDBVFy5

How confident are you that you're maximizing the impact #lab data can have on brand performance? Madeline Naylor from Norstella/MMIT (Managed Markets Insight & Technology) and Patrick Winniewicz from Quest Diagnostics have forgotten more about ways to leverage #lab data in #pharma than most will ever know! Check out this Q&A in BioPharma Dive and reach out if you want to talk about NorstellaLinQ!

🚀 Last Thursday, I had the opportunity to present at the SAVE DATA event in Antwerp, where I discussed “Go-to-market strategies for Digital Therapeutics (DTx)”. Interested to learn more? Contact Nathalie Niclaus or myself at LIVV company. In the ever-evolving field of DTx, creating a commercially viable business requires navigating various commercialization pathways, from direct-to-consumer (D2C) approaches to partnerships with pharmaceutical companies and employer channels. During the session, we also explored reimbursement pathways in the EU, such as Germany’s DiGa and France’s PECAN, providing a roadmap for DTx companies aiming to achieve market penetration and scalability. 🌍 A big thank you to the organizers, all the attendees and fellow speakers for an insightful afternoon. Together, we’re paving the way for the future of digital health. Melanie Verstraete Roel Naessens Jeroen Crappé Ludovic Ampe Bieke Van Gorp MEDVIA imec #DigitalHealth #DigitalTherapeutics #GoToMarket #HealthTech #DiGa #PECAN #marketaccess #BusinessModels #HealthInnovation

🍯 Everyone is looking for the holy grail for successful Pharma and Startup partnerships. The truth is, that there is no one size fits all! Paul Kirchmeier and I agree on the fact that both partners need to be a good fit in the context of product life cycle, business model and strategy. ❓ What is your key success factor for a fruitful partnership? #dtx #digitalhealthcare #partnerships Allis Health Ignited Vision by Susanne Gruber

Digital Therapeutics (DTx) are characterized by evidenced-based software and devices that deliver therapeutic interventions directly to patients through clinically validated programs. Find out more about the opportunity DTx presents for enhanced healthcare experiences and outcomes in our latest guide: https://bit.ly/3PeMM1T #DigitalTherapeutics #DTx #AvalereHealth #HealthcareTech